Abstract
Objective
To study the efficacy of transcatheter arterial chemoembolization (TACE) combined with percutaneous acetic acid injection (PAI) on massive hepatocellular carcinoma (MHCC).
Methods
TACE was performed in 57 patients with MHCC, which were randomly divided into group A (n = 28) and group B (n = 29). Patients in the group A received conventional TACE for the first time and then received low dose TACE (10 mg mitomycin C) for the repeated treatment, Re-examined CT scans after TACE for a week. Based on filled status of Lipiodol in the Lesions, PAI was underwent in the area of rarefaction or defect filled by Lipiodol. Patients in the group B received conventional TACE. Then The survival rate and masses variation and hepatic function and α-FP and side effects were observed.
Results
The 1-, 2-and 3-year survival rate after TACE were 96.4%, 78.6% and 32.1% for group A, and 65.5%, 48.3% and 20.7% for group B. Masses diminution were found in all patients in group A, while 20 cases were found in group B, unchanged in 5 cases and enlarged in 4 cases.
Conclusion
The efficacy of TACE combined with PAI are significantly better than that of TACE only, low dose TACE produces less hepatic damage and less side effect.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Zhu KS, Shan H, Huang MS, et al. The content changes of serum liver fibrosis indicators after transarterial chemoembolization for primary hepatic carcinoma and their clinical significance. J Clin Radiol (Chinese), 2000, 19: 208–210.
Lu W, Li YH, Li ZG, et al. A comparative study on necrosis and apoptosis of hepatocellular carcinoma cells after TACE with use of low-dose and conventional-dose anticancer drugs. Chin J Radiol (Chinese), 2003, 37: 232–234.
Hu DY, Li Z, Wang N, et al. TACE treatment of hepatic carcinoma: a comparative study of low dose versus conventional dose. J Clin Radiol (Chinese), 2004, 23: 502–506.
Ohnishi K, Ohyama N, Ito S, et al. Small hepatocellular carcinoma: treatment with us-guided intratumoral injection of acetic acid. Radiology, 1994, 193: 747–752.
Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer, 1992, 69: 925–929.
Lu GR, Li XF, Wang JY, et al. Treatment of liver cancer by percutaneous injection of acetic acid under ultrasound guidance. Chin J Ultrason (Chinese), 1999, 8: 229–231.
Zhou YC, Yang HF, Zhang JX, et al. Preliminary report of the chemo-ablation of hepatic neoplasms. Radiol Pract (Chinese), 2001, 16: 73–75.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, S., Hu, D., Huang, Y. et al. The double intervention clinical value and application research of TACE with PAI on massive hepatocellular carcinoma. Chin. -Ger. J. Clin. Oncol. 7, 128–130 (2008). https://doi.org/10.1007/s10330-007-0199-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-007-0199-9